Come up with a name for your new list and we'll add to it:
BioAtla raised a round of funding on June 11, 2015. Investors include
Pfizer Venture Investments.
BioAtla is a global biotechnology company developing novel monoclonal antibody and other protein therapeutic products utilizing our proprietary technologies for product design and development. The com…